NAU IB Capital

Equities

A293580

KR7293580007

Investment Management & Fund Operators

End-of-day quote Korea S.E. Other stock markets 18:00:00 2024-05-30 EDT			5-day change	1st Jan Change
964 ^KRW	+1.47%		-1.83%	-14.16%

2023	NAU IB Capital Reports Earnings Results for the Full Year Ended December 31, 2022	CI
2022	Tranche Update on NAU IB Capital's Equity Buyback Plan announced on August 18, 2021.	CI

Cell Meat announced that it has received $8.1 million in funding from NAU IB Capital, BNK Venture Investment, Strong Ventures, LLC, Ryukyungpsg Asset Management Inc

April 19, 2022

cellmeat CO., LTD. announced that it has received $8.1 million in a round of funding on April 20, 2022. The transaction included participation from returning investors NAU IB Capital, BNK Venture Investment, Strong Ventures, LLC, and Ryukyungpsg Asset Management Inc. The company has raised $14.1 million in funding till date.

Latest news about NAU IB Capital

NAU IB Capital Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-20	CI
Tranche Update on NAU IB Capital's Equity Buyback Plan announced on August 18, 2021.	22-08-18	CI
Tranche Update on NAU IB Capital's Equity Buyback Plan announced on August 18, 2021.	22-08-18	CI
Tranche Update on NAU IB Capital's Equity Buyback Plan announced on August 18, 2021.	22-08-18	CI
Tranche Update on NAU IB Capital's Equity Buyback Plan announced on August 18, 2021.	22-08-18	CI
Tranche Update on NAU IB Capital's Equity Buyback Plan announced on August 18, 2021.	22-08-18	CI
NAU IB Capital's Equity Buyback announced on August 18, 2021, has expired with 198,405 shares, representing 2.08% for KRW 1,987.81 million.	22-08-17	CI
Cell Meat announced that it has received $8.1 million in funding from NAU IB Capital, BNK Venture Investment, Strong Ventures, LLC, Ryukyungpsg Asset Management Inc	22-04-19	CI
NAU IB Capital announces an Equity Buyback for KRW 2,000 million worth of its shares.	21-08-18	CI
NAU IB Capital authorizes a Buyback Plan.	21-08-17	CI
Cellmeat CO., LTD. announced that it has received KRW 5 billion in funding from a group of investors	21-01-30	CI
Nau Ib Capital, C Squared Asset Management Co., Ltd. and Yangtze River Delta Venture Capital Fund, a fund managed by DT Capital Partners and Delta Venture Capital Investment Management Company acquired 11.94% stake in Bio Protech Inc. (XKON : A199290) from KoFC-Neoplux Pioneer Champ 2010-7, a fund managed by Neoplux Co., Ltd. for KRW 1 billion.	19-05-20	CI
Megazone Cloud Corp announced that it has received $45 million in funding from Korea Development Bank, KB Financial Group Inc., Nau Ib Capital and other investors	19-03-11	CI
Nau Ib Capital has completed an IPO in the amount of KRW 21.25 billion.	18-09-21	CI
Nau Ib Capital has filed an IPO.	18-06-08	CI
KPM TECH Co., Ltd. acquired 25.9% stake in Abion Inc. from a group of sellers for KRW 13.5 billion.	17-08-30	CI

Chart NAU IB Capital

Duration

Period

More charts

Company Profile

Nau IB Capital is a Korea-based company engaged in the new technology project financing business. The Company operates investment associations and private equity funds (PEF), mainly engaged in the investment and recovery of new technology business providers, venture companies and others.

Sector

Investment Management & Fund Operators

More about the company

Income Statement Evolution

More financial data

Sector Venture Capital

	1st Jan change	Capi.
NAU IB CAPITAL	-14.16%	65.58M
HERCULES CAPITAL, INC.	+18.42%	3.16B
UMBRA COMPANIES INC.	+12.82%	1.77B
HBM HEALTHCARE INVESTMENTS AG	+13.91%	1.59B
OCTOPUS TITAN VCT PLC	-11.54%	1.21B
MOLTEN VENTURES PLC	+19.42%	793M
CION INVESTMENT CORPORATION	+10.61%	674M
VERUSA HOLDING	+30.96%	561M
OCTOPUS APOLLO VCT PLC	-4.17%	506M
WOORI TECHNOLOGY INVESTMENT CO., LTD	+34.78%	489M

Venture Capital